Camba, Baby Girl .

HRN: 22-76-20  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2023
AMPICILLIN 250MG (VIAL)
03/25/2023
03/31/2023
IVT
45mg
Q12
Prematurity; Sepsis
Waiting Final Action 
03/25/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/25/2023
03/31/2023
IVT
13.5mg
OD
Prematurity; Sepsis
Waiting Final Action 
04/02/2023
CEFOTAXIME 500MG (VIAL)
04/02/2023
04/09/2023
IV
45mg
Q8hrs
PCAP
Waiting Final Action 
04/03/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
04/03/2023
04/23/2023
IV
10mg
Q48hrs
Severe Sepsis
Waiting Final Action 
04/03/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/03/2023
04/16/2023
IV
7mg
Q48hrs
Severe Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: